Clinical Features, Treatments, and Prognosis of Intramedullary Spinal Cord Metastases From Lung Cancer: A Case Series and Systematic Review
Open Access
- 31 March 2022
- journal article
- review article
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 19 (1) , 65-76
Abstract
Objective: Intramedullary spinal cord metastasis from lung cancer (ISCM-LC) are increasing in prevalence. We aim to investigate its clinical features, treatments and prognosis.Methods: We reported 6 ISCM-LC cases and conducted a systematic review. Descriptive summarization, survival analysis, and multivariate Cox regression analysis were performed to comprehensively study the disease.Results: All 6 patients had surgery. One used chemotherapy and the other had targeted drugs. Two patients died of ISCM-LC, 1 died of pulmonary embolism, 1 was alive, and 2 were lost to follow-up. We identified 197 ISCM-LC cases in literature with a mean age of 58 years and male preponderance. Small cell lung cancer accounted for 39.1%. The median interval from lung cancer to ISCM-LC was 7 months. Limb weakness was the most common symptom, and 45% cases progressed rapidly. Concomitant brain, leptomeningeal, and vertebral metastasis occurred to 55.8%, 20%, and 19.5%, respectively. Peritumoral edema appeared in 83.3%. Through survival analysis, we found sex, extraspinal metastasis, pathology, and improved symptoms affected the overall survival. Additionally, gross total resection (GTR) shared similar effectiveness with non-GTR, and other treatments following surgery hardly added extra effect. Surgery, improved symptoms, and sex were 3 independent prognostic factors after adjusting for confounding. The estimated median survival time was 5 months.Conclusion: The overall survival of ISCM-LC remains poor. Surgery is an independent protective factor for survival. Surgery should be considered once tolerated, and GTR might not be necessary. In addition, female patients with improved symptoms after intervention might have better overall survival.Keywords
This publication has 39 references indexed in Scilit:
- Intramedullary metastasis detected with 18F FDG-PET/CTRevista Española de Medicina Nuclear e Imagen Molecular, 2012
- Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry StudyJournal of Thoracic Oncology, 2010
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Retrospective study of 19 patients with intramedullary spinal cord metastasisClinical Neurology and Neurosurgery, 2009
- THE ACCURACY OF [18F]FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY AS CONFIRMED BY BIOPSY IN THE DIAGNOSIS OF SPINE METASTASES IN A CANCER POPULATIONNeurosurgery, 2009
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- INTRAMEDULLARY SPINAL EPENDYMOMASNeurosurgery, 2008
- Magnetic Resonance Imaging in the Management of Suspected Spinal Canal Disease in Patients with Known MalignancyClinical Radiology, 2000
- Intramedullary spinal cord metastasis: Report of three cases and review of the literatureSurgical Neurology, 1996
- Intramedullary spinal cord metastasesNeurology, 1972